Amplia Therapeutics Limited Share Price OTC Markets
Stocks
INNMF
AU0000023822
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1150 USD | +43.75% |
|
-.--% | +45.75% |
| 07-07 | Amplia Therapeutics Limited Announces Appointment of Brett Carter to Board, Effective July 6, 2026 | CI |
| 07-06 | Amplia Therapeutics Limited Announces Board Changes, Effective June 30, 2026 | CI |
| Market Cap | 71.86M 49.67M 43.57M 40.22M 37.17M 70.45M 4.76B 484M 188M 2.33B 187M 182M 8.08B | P/E 2027 * |
-6.09x | P/E 2028 * | -23.3x |
|---|---|---|---|---|---|
| Enterprise Value | 56.36M 38.96M 34.17M 31.55M 29.15M 55.26M 3.73B 379M 147M 1.83B 146M 143M 6.34B | EV / Sales 2027 * |
-
| EV / Sales 2028 * | 5.04x |
| Free-Float |
84.81% | Yield 2027 * |
-
| Yield 2028 * | - |
| 1 day | +43.75% | ||
| 1 month | +15.00% | ||
| 3 months | -17.86% | ||
| 6 months | -4.17% | ||
| Current year | +45.75% |
| 1 month | 0.08 |  | 0.12 |
| Current year | 0.06 | | 0.27 |
| 1 year | 0.05 | | 0.27 |
| 3 years | 0.02 | | 0.27 |
| 5 years | 0.02 | | 0.27 |
| 10 years | 0.01 | | 1.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 04/12/2022 | |
Hamish George
DFI | Director of Finance/CFO | - | 30/09/2021 |
Jason Lickliter
CTO | Chief Tech/Sci/R&D Officer | - | 11/05/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Peach
BRD | Director/Board Member | 70 | 01/09/2015 |
Warwick Tong
CHM | Chairman | - | 24/05/2018 |
Jane Bell
CHM | Chairman | - | 29/06/2026 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +43.75% | -.--% | - | - | 53.4M | |
| -1.53% | +0.78% | +72.33% | +129.70% | 57.72B | |
| -2.45% | -7.83% | +63.92% | +83.15% | 52.65B | |
| +3.27% | +8.91% | +21.21% | +486.76% | 24.46B | |
| -0.81% | -0.42% | -16.24% | -12.47% | 23.84B | |
| -0.11% | -0.67% | +37.53% | -6.26% | 19.28B | |
| -0.24% | +5.11% | +38.76% | -26.41% | 17.8B | |
| +2.34% | +12.50% | +224.02% | +380.99% | 17.29B | |
| -1.84% | +0.64% | +34.53% | - | 15.28B | |
| -1.70% | +3.98% | +28.96% | +190.57% | 14.35B | |
| Average | +4.07% | +5.51% | +56.11% | +153.25% | 26.96B | |
| Weighted average by Cap. | -0.71% | +3.12% | +57.29% | +141.61% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | - | 10M 6.91M 6.06M 5.6M 5.17M 9.8M 662M 67.29M 26.15M 324M 25.96M 25.39M 1.12B |
| Net income | -11.6M -8.02M -7.03M -6.49M -6M -11.37M -768M -78.05M -30.33M -376M -30.11M -29.45M -1.3B | -3.6M -2.49M -2.18M -2.02M -1.86M -3.53M -238M -24.22M -9.41M -117M -9.34M -9.14M -405M |
| Net Debt | -15.5M -10.71M -9.4M -8.68M -8.02M -15.2M -1.03B -104M -40.52M -502M -40.23M -39.35M -1.74B | -21.5M -14.86M -13.03M -12.03M -11.12M -21.08M -1.42B -145M -56.21M -696M -55.81M -54.59M -2.42B |
Employees
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/06/26 | US$0.1150 | +43.75% | 37,250 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.1400AUD
Average target price
0.4200AUD
Spread / Average Target
+200.00%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ATX Stock
- INNMF Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
